HIV downregulates interferon-stimulated genes in primary macrophages

Journal of Interferon and Cytokine Research

Volumn 33, Issue 2, 2013, Pages 90-95

  Wie, Seong Heon ^a   Du, Pinyi ^b   Luong, Tiffany Q ^b   Rought, Steffney E ^b   Beliakova Bethell, Nadejda ^c   Lozach, Jean ^d   Corbeil, Jacques ^e   Kornbluth, Richard S ^f   Richman, Douglas D ^b,c,g   Woelk, Christopher H ^b,c  

^a The Catholic University of Korea   (South Korea)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d ILLUMINA INC   (United States)

^e LAVAL UNIVERSITY   (Canada)

^f BIOTHERAPEUTICS INC   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; AXL PROTEIN; IFI27 PROTEIN; IFI44 PROTEIN; INTERFERON; INTERFERON STIMULATED GENE FACTOR 15; INTERFERON STIMULATED GENE FACTOR 3; OAS1 PROTEIN; OAS3 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRUS PROTEIN; XAF1 PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; INTERFERON INDUCTION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN FOLDING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; VIRUS IMMUNITY; VIRUS REPLICATION;

CELLS, CULTURED; DOWN-REGULATION; HIV; HIV INFECTIONS; HUMANS; INTERFERONS; MACROPHAGES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84873617788     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0052     Document Type: Article

References (41)

1. Asmuth DM, Murphy RL, Rosenkranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li XD, Wahl SM, Shore J, Janik J, Lempicki RA, Simpson Y, Pollard RB. 2010. Safety, tolerability, and mechanisms of an-tiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial. J Infect Dis 201(11):1686-1696.
2. Chana G, Lucero G, Salaria S, Lozach J, Du P, Woelk CH, Everall I. 2009. Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine. Schizophr Res 113(2-3):273-276.
3. Cheney KM, McKnight A. 2010. Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication. PLoS One 5(10):e13521.
4. Emilie D, Burgard M, Lascoux-Combe C, Laughlin M, Krzysiek R, Pignon C, Rudent A, Molina JM, Livrozet JM, Souala F, Chene G, Grangeot-Keros L, Galanaud P, Sereni D, Rouzioux C. 2001. Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study. Aids 15(11):1435-1437. (Pubitemid 32662296)
5. Fonteneau JF, Larsson M, Beignon AS, McKenna K, Dasilva I, Amara A, Liu YJ, Lifson JD, Littman DR, Bhardwaj N. 2004. Human immunodeficiency virus type 1 activates plasmacy-toid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 78(10):5223-5232. (Pubitemid 38581474)
6. Gendelman HE, Baca L, Turpin JA, Kalter DC, Hansen BD, Orenstein JM, Friedman RM, Meltzer MS. 1990. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha. AIDS Res Hum Retroviruses 6(8):1045-1049. (Pubitemid 20300068)
7. Goodbourn S, Didcock L, Randall RE. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81(Pt 10):2341-2364.
8. Hartshorn KL, Neumeyer D, Vogt MW, Schooley RT, Hirsch MS. 1987. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses 3(2):125-133. (Pubitemid 18079257)
9. Hatzakis A, Gargalianos P, Kiosses V, Lazanas M, Sypsa V, Anastassopoulou C, Vigklis V, Sambatakou H, Botsi C, Paraskevis D, Stalgis C. 2001. Low-dose IFN-alpha mono-therapy in treatment-naive individuals with HIV-1 infection: evidence of potent suppression of viral replication. J Interferon Cytokine Res 21(10):861-869. (Pubitemid 33078525)
10. Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J. 2009. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One 4(5):e5674.
11. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immuno deficiency virus in vitro. J Exp Med 169(3):1137-1151. (Pubitemid 19085845)
12. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. 1990. The role of interferons in the control of HIV replication in macrophages. Clin Immunol Immunopathol 54(2):200-219. (Pubitemid 20042221)
13. Kunzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM. 1995. Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. J Infect Dis 171(4): 822-828.
14. Kunzi MS, Pitha PM. 1996. Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication. J Interferon Cytokine Res 16(11):919-927. (Pubitemid 26400684)
15. Liptakova H, Kontsekova E, Alcami A, Smith GL, Kontsek P. 1997. Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2. Virology 232(1):86-90. (Pubitemid 27244465)
16. Liu YJ. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275-306.
17. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408. (Pubitemid 34164012)
18. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. 2011. The IFITM proteins inhibit HIV-1 infection. J Virol 85(5):2126-2137.
19. Meylan PR, Guatelli JC, Munis JR, Richman DD, Kornbluth RS. 1993. Mechanisms for the inhibition of HIV replication by interferons-alpha,-beta, and-gamma in primary human macrophages. Virology 193(1):138-148.
20. Mogensen KE, Lewerenz M, Reboul J, Lutfalla G, Uze G. 1999. The type I interferon receptor: structure, function, and evolution of a family business. J Interferon Cytokine Res 19(10):1069-1098. (Pubitemid 29502774)
21. Muto NF, Martinand-Mari C, Adelson ME, Suhadolnik RJ. 1999. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct. J Virol 73(11):9021-9028. (Pubitemid 29487055)
22. Nieto L, Angeil J, Gazzard B, Cahn P, Ward D, Ramirez-Ronda C, Taglietti M, Greaves W. 2001. Antiviral activity and toler-ability of Peg-Intron in HIV patients failing HAART. The 1st Conference on HIV Pathogenesis and Treatment, Buenos Aires, Argentina.
23. Peng G, Lei KJ, Jin W, Greenwell-Wild T, Wahl SM. 2006. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 203(1):41-46.
24. Pestka S, Krause CD, Walter MR. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202:8-32. (Pubitemid 39576902)
25. Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS. 1989. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science 244(4904):575-577. (Pubitemid 19140811)
26. Schroder HC, Ugarkovic D, Merz H, Kuchino Y, Okamoto T, Muller WE. 1990. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfec-tion with HIV LTR-2¢,5¢-oligoadenylate synthetase hybrid gene. FASEB J 4(13):3124-3130.
27. Schugt I, Kreuter A, Schlottmann R, Bader A, Altmeyer P, Brockmeyer NH. 2003. Pegylated interferon alfa-2b: a new therapeutic option in the treatment of early-stage HIV infection. 10th Conference on Retroviruses and Opporutnistic Infections Session 14, Boston, MA, USA.
28. Sheehy AM, Gaddis NC, Malim MH. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9(11):1404-1407. (Pubitemid 37466190)
29. Shirazi Y, Pitha PM. 1992. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J Virol 66(3):1321-1328.
30. Sirois M, Robitaille L, Allary R, Shah M, Woelk CH, Estaquier J, Corbeil J. 2011. TRAF6 and IRF7 control HIV replication in macrophages. PLoS One 6(11):e28125.
31. Sperber SJ, Gocke DJ, Haberzettl C, Kuk R, Schwartz B, Pestka S. 1992. Anti-HIV-1 activity of recombinant and hybrid species of interferon-alpha. J Interferon Res 12(5):363-368.
32. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264. (Pubitemid 28411130)
33. Uze G, Mogensen KE, Aguet M. 1985. Receptor dynamics of closely related ligands: "fast" and "slow" interferons. EMBO J 4(1):65-70.
34. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. 2008. The interferon-induced protein BST-2 restricts HIV-1 release and is down-regulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3(4):245-252. (Pubitemid 351494713)
35. Waddell SJ, Popper SJ, Rubins KH, Griffiths MJ, Brown PO, Levin M, Relman DA. 2010. Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS One 5(3):e9753.
36. Wahl SM, Greenwell-Wild T, Peng G, Ma G, Orenstein JM, Vazquez N. 2003. Viral and host cofactors facilitate HIV-1 replication in macrophages. J Leukoc Biol 74(5):726-735. (Pubitemid 38040349)
37. Woelk CH, Beliakova-Bethell N, Goicoechea M, Zhao Y, Du P, Rought SE, Lozach J, Perez-Santiago J, Richman DD, Smith DM, Little SJ. 2010. Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4 + T-cell recovery. AIDS 24(2):217-222.
38. Woelk CH, Frost SD, Richman DD, Higley PE, Kosakovsky Pond SL. 2007. Evolution of the interferon alpha gene family in eutherian mammals. Gene 397(1-2):38-50. (Pubitemid 46977131)
39. Woelk CH, Ottones F, Plotkin CR, Du P, Royer DR, Rought SE, Lozach J, Sasik R, Kornbluth RS, Richman D, Corbeil J. 2004. Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res Hum Retroviruses 20(11):1210-1222. (Pubitemid 39557871)
40. Yamada O, Hattori N, Kurimura T, Kita M, Kishida T. 1988. Inhibition of growth of HIV by human natural interferon in vitro. AIDS Res Hum Retroviruses 4(4):287-294.
41. Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302(5647):1056-1060. (Pubitemid 37386201)